Brief: CEL-SCI Gets FDA Go-Ahead For Study Of Multikine In Treatment Of Head, Neck Cancer

CEL-SCI

08/05/2024 14:18

May 8 (Reuters) - CEL-SCI Corp  CVM.A :
    * CEL-SCI RECEIVES FDA GO-AHEAD FOR ITS CONFIRMATORY STUDY
OF
MULTIKINE IN THE TREATMENT OF HEAD & NECK CANCER

Source text for Eikon:  ID:nBw9HRlyba 
Further company coverage:  CVM.A 

 ((Reuters.Briefs@thomsonreuters.com;))